Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""INFLAMMATORY bowel diseases"" wg kryterium: Temat


Starter badań:

Tytuł :
Effects of yoga in inflammatory bowel diseases and on frequent IBD-associated extraintestinal symptoms like fatigue and depression.
Autorzy :
Wilke E; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Germany. Electronic address: .
Reindl W; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Germany.
Thomann PA; Center for Mental Health, Odenwald District Healthcare Center, Erbach, Germany.
Ebert MP; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Germany.
Wuestenberg T; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Germany.
Thomann AK; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Germany.
Pokaż więcej
Źródło :
Complementary therapies in clinical practice [Complement Ther Clin Pract] 2021 Nov; Vol. 45, pp. 101465. Date of Electronic Publication: 2021 Jul 29.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Inflammatory Bowel Diseases*/complications
Inflammatory Bowel Diseases*/therapy
Meditation*
Yoga*
Depression/etiology ; Depression/therapy ; Fatigue/etiology ; Fatigue/therapy ; Humans ; Quality of Life
Czasopismo naukowe
Tytuł :
Complications and adverse effects related to surgical and medical treatment in patients with inflammatory bowel disease in a prospectively recruited population-based cohort.
Autorzy :
Rönnblom A; Section of Gastroenterology and Hepatology, Akademiska Hospital, Magtarmmottagningen, Uppsala, Sweden.
Ljunggren Ö; Department of Medical Sciences, Uppsala University, Uppsala University Hospital, Uppsala, Sweden.
Karlbom U; Department of Surgical Sciences, Uppsala University, University Hospital, Uppsala, Sweden.
Pokaż więcej
Źródło :
Scandinavian journal of gastroenterology [Scand J Gastroenterol] 2021 Nov; Vol. 56 (11), pp. 1296-1303. Date of Electronic Publication: 2021 Aug 08.
Typ publikacji :
Journal Article
MeSH Terms :
Colitis, Ulcerative*/drug therapy
Colitis, Ulcerative*/surgery
Crohn Disease*/drug therapy
Crohn Disease*/surgery
Drug-Related Side Effects and Adverse Reactions*
Inflammatory Bowel Diseases*/drug therapy
Inflammatory Bowel Diseases*/surgery
Cohort Studies ; Humans
Czasopismo naukowe
Tytuł :
Acceptance of SARS-CoV-2 Vaccination Among a Cohort of IBD Patients From Southern Italy: A Cross-Sectional Survey.
Autorzy :
Crispino F; Gastroenterology & Hepatology Section, PROMISE, University of Palermo, Palermo, Italy.
Brinch D; Gastroenterology & Hepatology Section, PROMISE, University of Palermo, Palermo, Italy.
Carrozza L; Gastroenterology & Hepatology Section, PROMISE, University of Palermo, Palermo, Italy.
Cappello M; Gastroenterology & Hepatology Section, PROMISE, University of Palermo, Palermo, Italy.
Pokaż więcej
Źródło :
Inflammatory bowel diseases [Inflamm Bowel Dis] 2021 Oct 20; Vol. 27 (11), pp. e134-e135.
Typ publikacji :
Letter
MeSH Terms :
COVID-19*/epidemiology
COVID-19*/prevention & control
Gastroenterologists*
Inflammatory Bowel Diseases*/epidemiology
Inflammatory Bowel Diseases*/psychology
Patient Acceptance of Health Care*/psychology
Patient Acceptance of Health Care*/statistics & numerical data
Vaccination*/psychology
Vaccination*/statistics & numerical data
COVID-19 Vaccines/*therapeutic use
Directive Counseling/*methods
Age Factors ; Attitude to Health ; Family ; Humans ; Influenza Vaccines/therapeutic use ; Italy/epidemiology ; Physician's Role ; SARS-CoV-2
Opinia redakcyjna
Tytuł :
Risk and characteristics of tuberculosis after anti-tumor necrosis factor therapy for inflammatory bowel disease: a hospital-based cohort study from Korea.
Autorzy :
Lee JY; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Oh K; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Hong HS; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Kim K; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Hong SW; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Park JH; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Hwang SW; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Yang DH; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Ye BD; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Byeon JS; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Myung SJ; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Yang SK; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Lee HS; Department of Biochemistry, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Jo KW; Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea. .
Park SH; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea. .
Pokaż więcej
Źródło :
BMC gastroenterology [BMC Gastroenterol] 2021 Oct 20; Vol. 21 (1), pp. 390. Date of Electronic Publication: 2021 Oct 20.
Typ publikacji :
Journal Article
MeSH Terms :
Inflammatory Bowel Diseases*/drug therapy
Inflammatory Bowel Diseases*/epidemiology
Tuberculosis*/epidemiology
Cohort Studies ; Hospitals ; Humans ; Infliximab/adverse effects ; Republic of Korea/epidemiology ; Tumor Necrosis Factor Inhibitors
Czasopismo naukowe
Tytuł :
SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy.
Autorzy :
Selim R; Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford OX3 9DU, UK; Faculty of Medicine, Imperial College London, London, UK.
Wellens J; Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford OX3 9DU, UK; Translational Research for Gastrointestinal Diseases, University Hospitals Leuven, Leuven, Belgium. Electronic address: .
Marlow L; Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford OX3 9DU, UK.
Satsangi JJ; Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford OX3 9DU, UK.
Pokaż więcej
Źródło :
The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2021 Dec; Vol. 6 (12), pp. 989. Date of Electronic Publication: 2021 Oct 14.
Typ publikacji :
Letter
MeSH Terms :
COVID-19 Vaccines*
Immunocompromised Host*
Biological Therapy/*adverse effects
COVID-19/*immunology
Inflammatory Bowel Diseases/*immunology
Vaccination Coverage/*statistics & numerical data
Vaccination Refusal/*statistics & numerical data
Adult ; Aged ; Aged, 80 and over ; COVID-19/complications ; COVID-19/prevention & control ; Female ; Humans ; Immunosuppressive Agents/adverse effects ; Immunosuppressive Agents/therapeutic use ; Inflammatory Bowel Diseases/complications ; Inflammatory Bowel Diseases/drug therapy ; Male ; Middle Aged ; Patient Acceptance of Health Care/statistics & numerical data ; United Kingdom
Opinia redakcyjna
Tytuł :
Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease.
Autorzy :
Alexander JL; Department of Metabolism, Digestion and Reproduction, Imperial College London, London SW7 2AZ, UK; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK.
Selinger CP; Leeds Gastroenterology Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Powell N; Department of Metabolism, Digestion and Reproduction, Imperial College London, London SW7 2AZ, UK; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK. Electronic address: .
Pokaż więcej
Corporate Authors :
British Society of Gastroenterology Inflammatory Bowel Disease section and the Inflammatory Bowel Disease Clinical Research Group
Źródło :
The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2021 Dec; Vol. 6 (12), pp. 987-988. Date of Electronic Publication: 2021 Oct 13.
Typ publikacji :
Letter
MeSH Terms :
Immunocompromised Host*
COVID-19/*immunology
COVID-19/*prevention & control
COVID-19 Vaccines/*administration & dosage
Immunization, Secondary/*methods
Immunosuppressive Agents/*adverse effects
Inflammatory Bowel Diseases/*immunology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; COVID-19/complications ; Child ; Humans ; Immunization Schedule ; Immunization, Secondary/standards ; Immunosuppressive Agents/therapeutic use ; Inflammatory Bowel Diseases/complications ; Inflammatory Bowel Diseases/drug therapy ; Middle Aged ; Practice Guidelines as Topic ; United Kingdom ; Young Adult
Opinia redakcyjna
Tytuł :
Proactive therapeutic drug monitoring is more effective than conventional management in inducing fecal calprotectin remission in inflammatory bowel disease.
Autorzy :
Fernandes SR; Department of Gastrenterology and Hepatology, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
Serrazina J
Rodrigues IC
Bernardo S
Rita Gonçalves A
Valente A
Baldaia C
Santos PM
Correia LA
Tato Marinho R
Pokaż więcej
Źródło :
European journal of gastroenterology & hepatology [Eur J Gastroenterol Hepatol] 2021 Dec 01; Vol. 33 (12), pp. 1539-1546.
Typ publikacji :
Journal Article
MeSH Terms :
Inflammatory Bowel Diseases*/diagnosis
Inflammatory Bowel Diseases*/drug therapy
Leukocyte L1 Antigen Complex*
Drug Monitoring ; Gastrointestinal Agents/adverse effects ; Humans ; Prospective Studies ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic.
Autorzy :
McGregor CG; Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, University of Oxford, Oxford, UK .
Adams A; Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, University of Oxford, Oxford, UK.
Sadler R; Department of Laboratory Immunology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Arancibia-Cárcamo CV; Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, University of Oxford, Oxford, UK.
Palmer R; Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, University of Oxford, Oxford, UK.
Ambrose T; Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, University of Oxford, Oxford, UK.
Brain O; Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, University of Oxford, Oxford, UK.
Walsh A; Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, University of Oxford, Oxford, UK.
Klenerman P; Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, University of Oxford, Oxford, UK.
Travis SP; Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, University of Oxford, Oxford, UK.
Croft NM; Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London, UK.; Departments of Gastroenterology and Paediatric Gastroenterology, Royal London Hospital, Barts Health NHS Trust, London, UK.
Lindsay JO; Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London, UK.; Departments of Gastroenterology and Paediatric Gastroenterology, Royal London Hospital, Barts Health NHS Trust, London, UK.
Satsangi J; Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, University of Oxford, Oxford, UK.
Pokaż więcej
Źródło :
Gut [Gut] 2021 Dec; Vol. 70 (12), pp. 2398-2400. Date of Electronic Publication: 2021 Feb 12.
Typ publikacji :
Letter; Comment
MeSH Terms :
COVID-19*
Inflammatory Bowel Diseases*/drug therapy
Inflammatory Bowel Diseases*/epidemiology
Antibodies, Monoclonal, Humanized ; Humans ; Infliximab ; Pandemics ; SARS-CoV-2 ; United Kingdom/epidemiology
Opinia redakcyjna
Tytuł :
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study.
Autorzy :
Bezzio C; Rho (Milan), Italy.
Armuzzi A; Rome, Italy.
Furfaro F; Rozzano (Milan), Italy.
Ardizzone S; Milan, Italy.
Milla M; Florence, Italy.
Carparelli S; San Giovanni Rotondo, Italy.
Orlando A; Palermo, Italy.
Caprioli FA; Milan, Italy.
Castiglione F; Naples, Italy.
Viganò C; Monza, Italy.
Ribaldone DG; Turin, Italy.
Zingone F; Padua, Italy.
Monterubbianesi R; Rome, Italy.
Imperatore N; Naples, Italy.
Festa S; Rome, Italy.
Daperno M; Turin, Italy.
Scucchi L; Rome, Italy.
Ferronato A; Vicenza, Italy.
Pastorelli L; Milan, Italy.
Balestrieri P; Rome, Italy.
Ricci C; Brescia, Italy.
Cappello M; Palermo, Italy.
Felice C; Treviso, Italy.
Fiorino G; Rozzano (Milan), Italy.
Saibeni S; Rho (Milan), Italy.
Pokaż więcej
Corporate Authors :
Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Dec; Vol. 54 (11-12), pp. 1432-1441. Date of Electronic Publication: 2021 Oct 25.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
COVID-19*
Colitis, Ulcerative*
Crohn Disease*/complications
Crohn Disease*/drug therapy
Crohn Disease*/epidemiology
Inflammatory Bowel Diseases*/complications
Inflammatory Bowel Diseases*/drug therapy
Inflammatory Bowel Diseases*/epidemiology
Aged ; Humans ; SARS-CoV-2 ; Tumor Necrosis Factor Inhibitors
Czasopismo naukowe
Tytuł :
Clostridioides difficile Infection in Pediatric Inflammatory Bowel Disease: A Clinician's Dilemma.
Autorzy :
Conrad MA; Division of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Kelsen JR; Division of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Pokaż więcej
Źródło :
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2021 Nov 17; Vol. 10 (Supplement_3), pp. S41-S45.
Typ publikacji :
Journal Article
MeSH Terms :
Clostridioides difficile*
Clostridium Infections*/complications
Clostridium Infections*/diagnosis
Inflammatory Bowel Diseases*/complications
Inflammatory Bowel Diseases*/diagnosis
Child ; Clostridioides ; Humans ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease.
Autorzy :
Dai C; Department of Gastroenterology, First Affiliated Hospital, China Medical University, Shenyang City, Liaoning Province, China.
Jiang M; Department of Gastroenterology, First Affiliated Hospital, China Medical University, Shenyang City, Liaoning Province, China.
Huang YH; Department of Gastroenterology, First Affiliated Hospital, China Medical University, Shenyang City, Liaoning Province, China.
Pokaż więcej
Źródło :
Inflammatory bowel diseases [Inflamm Bowel Dis] 2021 Nov 15; Vol. 27 (12), pp. e156.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Herpes Zoster*/chemically induced
Herpes Zoster*/epidemiology
Inflammatory Bowel Diseases*/complications
Inflammatory Bowel Diseases*/drug therapy
Herpesvirus 3, Human ; Humans ; Tumor Necrosis Factor Inhibitors
Czasopismo naukowe
Tytuł :
[Effects of SARS-CoV-2 Infection on Symptoms and Therapy of Inflammatory Bowel Disease].
Autorzy :
Teich N; Internistische Gemeinschaftspraxis für Verdauungs- und Stoffwechselkrankheiten, Leipzig, Germany.
Ludewig C; Internistische Gemeinschaftspraxis für Verdauungs- und Stoffwechselkrankheiten, Leipzig, Germany.
Schmelz R; Medizinische Klinik und Poliklinik 1, Universitätsklinikum Carl Gustav Carus Dresden, Dresden, Germany.
Bästlein EC; Magen Darm Zentrum Wiener Platz, Köln, Germany.
Geißler S; Praxisgemeinschaft für Rheumatologie und Gastroenterologie, Cottbus, Germany.
Nagl S; III. Medizinische Klinik, Universitätsklinikum Augsburg, Augsburg, Germany.
Walldorf J; Universitätsklinik für Innere Medizin I, Martin-Luther-Universität Halle-Wittenberg Medizinische Fakultät, Halle, Germany.
Krause T; Gastroenterologie Opernstraße, Kassel, Germany.
Maaser C; Ambulanzzentrum Gastroenterologie am Klinikum Lüneburg, Lüneburg, Germany.
Mohl W; Zentrum für Gastroenterologie Saar MVZ GmbH Saarbrücken, Saarbrücken, Germany.
Wedemeyer HH; Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover, Hannover, Germany.
Bauer T; Gemeinschaftspraxis für Gastroenterologie und Kindergastroenterologie, Freinurg, Germany.
Büning C; Innere Medizin, Krankenhaus Waldfriede, Berlin, Germany.
Grunert P; Klinik für Innere Medizin IV (Gastroenterologie, Hepatologie und Infektiologie), Universitatsklinikum Jena, Jena, Germany.
Hasselblatt P; Department of Medicine II, University Hospital Freiburg, Freiburg, Germany.
Hänschen M; MVZ Polymed - ambulantes Praxiszentrum, Chemnitz, Germany.
Kahl M; Fachinternistische Schwerpunktpraxis, Hamburg, Germany.
Engelke O; Internistische Gemeinschaftspraxis Wanne-Eickel, Herne, Germany.
Schubert S; MVZ für Gastroenterologie am Bayerischen Platz, Berlin, Germany.
Holler B; Klinik und Poliklinik für Onkologie, Gastroenterologie, Hepatologie, Pneumologie und Infektiologie, Universitätsklinikum Leipzig, Germany.
Streetz K; Evangelisches Krankenhaus Kalk gGmbH, Köln, Germany.
Arnim UV; Department of Gastroenterology, Hepatology and Infectious diseases, Universitätsklinikum Magdeburg AöR, Magdeburg, Germany.
Schmidt K; Kompetenznetz Darmerkrankungen e.V., Kiel, Germany.
Stallmach A; Klinik für Innere Medizin IV (Gastroenterologie, Hepatologie und Infektiologie), Universitatsklinikum Jena, Jena, Germany.
Pokaż więcej
Transliterated Title :
Auswirkungen einer SARS-CoV-2-Infektion auf Symptomatik und Therapie chronisch-entzündlicher Darmerkrankungen.
Corporate Authors :
für die German IBD Study Group
Collaborators:
Jochen Maul, Berlin
Axel Schweitzer, Münster
Wolfgang Breit, Dinkelsbühl
Jan-Hinnerk Hofer, Köln
Marc Eisold, Mössingen
Michael R. Mroß, Berlin
Stefanie Howaldt, Hamburg
Stefanie Strobl, Ingolstadt
Robert Ehehalt, Heidelberg
Klaus Schmidt, Lübeck
Carsten Triller, Heinsberg
Serhat Aymaz, Düren
Thorsten Brechmann, Bochum
Axel Dignaß, Frankfurt
Elisabeth Schnoy, Augsburg
Bernd Swarovsky, Albstadt
Dr. med. Birgit Gerhard, Berlin
Doris Zink, Nürnberg
Ulrich Finger, Berlin
Franz Josef Heil, Andernach
Gerd-Rüdiger Franke, Dinkelsbühl
Günther Böhm, Ludwigshafen
Jens Hunkemöller, Oberberg
Martin Schmidt-Lauber, Oldenburg
Mirko Vonderach, Oldenburg
Olaf Mensler, Oberberg
Rainer Kunz, Fürstenfeldbruck
Richard Kölble, Düsseldorf
Christoph Rother, Sundern
Ulf Klönne, Göttingen
Ulrich Graefe, Berlin
Wolfgang Schwarz, Hamburg
Georg Schmitz, Düren
Hans Vibrans, Chemnitz
Thomas Witthöft, Stade
Tobias Klugmann, Leipzig
Martin Reuther, Lilienthal
Frank Bülow, Kassel
Carsten Ising, Waldbröl
Christoph Balzer, Schwandorf
Julia Morgenstern, Köln
Markus Casper, Saarbrücken
Ron Winograd, Aachen
Tilman Pickartz, Greifswald
Marco Wagner, Wipperfürth
Christoph Schmidt, Bonn
Wolfgang Vogt, Esslingen
Sabine Blau, Frankfurt/Main
Rolf Seipel, Kronach
Gisela Felten, Herne
Philipp A. Reuken, Jena
Jörg Kapp, Uelzen
Maximilian Gemeinhardt, Garmisch-Partenkirchen
Jörg Christian Metzler, Schwäbisch Gmünd
Martin Hoffstadt, Iserlohn
Susanne Wüchner-Hofmann, Darmstadt
Źródło :
Zeitschrift fur Gastroenterologie [Z Gastroenterol] 2021 Nov; Vol. 59 (11), pp. 1189-1196. Date of Electronic Publication: 2021 Jul 16.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
Inflammatory Bowel Diseases*/diagnosis
Inflammatory Bowel Diseases*/drug therapy
COVID-19 Testing ; Humans ; Retrospective Studies ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Mucocutaneous manifestations in patients with inflammatory bowel disease: a decade study from a Greek cohort.
Autorzy :
Koumaki D; Department of Dermatology, University Hospital of Heraklion.
Machaira A; Department of Gastroenterology, University Hospital of Heraklion, Crete.
Katoulis AC; 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, Medical School, 'Attikon' General University Hospital, Haidari, Athens.
Bitados P; Dermatology Department, University Hospital of Heraklion, Medical School of Crete, Heraklion, Crete, Greece.
Orfanoudaki E; Department of Gastroenterology, University Hospital of Heraklion, Crete.
Foteinogiannopoulou K; Department of Gastroenterology, University Hospital of Heraklion, Crete.
Stefanidou M; Department of Dermatology, University Hospital of Heraklion.
Krasagakis K; Department of Dermatology, University Hospital of Heraklion.
Koutroubakis IE; Department of Gastroenterology, University Hospital of Heraklion, Crete.
Pokaż więcej
Źródło :
European journal of gastroenterology & hepatology [Eur J Gastroenterol Hepatol] 2021 Nov 01; Vol. 33 (11), pp. 1387-1393.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Colitis, Ulcerative*/diagnosis
Colitis, Ulcerative*/drug therapy
Colitis, Ulcerative*/epidemiology
Crohn Disease*/diagnosis
Crohn Disease*/drug therapy
Crohn Disease*/epidemiology
Inflammatory Bowel Diseases*/diagnosis
Inflammatory Bowel Diseases*/epidemiology
Adult ; Aged ; Greece/epidemiology ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
[Cost of illness of inflammatory bowel disease in Germany].
Autorzy :
Schnorbach MT; Evangelisches Krankenhaus Kalk, Köln, Germany.
Kruis W; Evangelisches Krankenhaus Kalk, Köln, Germany.
Pokaż więcej
Transliterated Title :
Krankheitskosten chronisch entzündlicher Darmerkrankungen in Deutschland.
Źródło :
Zeitschrift fur Gastroenterologie [Z Gastroenterol] 2021 Nov; Vol. 59 (11), pp. 1173-1188. Date of Electronic Publication: 2020 Aug 31.
Typ publikacji :
Journal Article
MeSH Terms :
Colitis*
Inflammatory Bowel Diseases*/diagnosis
Inflammatory Bowel Diseases*/epidemiology
Inflammatory Bowel Diseases*/therapy
Cost of Illness ; Germany/epidemiology ; Health Care Costs ; Humans ; Prevalence
Czasopismo naukowe
Tytuł :
Multisystem Autoimmune Inflammatory Disease, Including Colitis, Due to Inborn Error of Immunity.
Autorzy :
Malik A; Department of Pediatrics, Dalhousie University and IWK Health Center, Halifax, Nova Scotia, Canada.
Stringer E; Department of Pediatrics, Dalhousie University and IWK Health Center, Halifax, Nova Scotia, Canada.
Warner N; International Early Onset Pediatric Inflammatory Bowel Disease Cohort Study, The Hospital for Sick Children, Toronto, Ontario, Canada.
van Limbergen J; Department of Pediatrics, Dalhousie University and IWK Health Center, Halifax, Nova Scotia, Canada.
Vandersteen A; Department of Pediatrics, Dalhousie University and IWK Health Center, Halifax, Nova Scotia, Canada.
Muise A; International Early Onset Pediatric Inflammatory Bowel Disease Cohort Study, The Hospital for Sick Children, Toronto, Ontario, Canada.
Derfalvi B; Department of Pediatrics, Dalhousie University and IWK Health Center, Halifax, Nova Scotia, Canada .
Pokaż więcej
Źródło :
Pediatrics [Pediatrics] 2021 Nov; Vol. 148 (5). Date of Electronic Publication: 2021 Oct 22.
Typ publikacji :
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Autoimmune Diseases/*genetics
Inflammatory Bowel Diseases/*genetics
Transmembrane Activator and CAML Interactor Protein/*genetics
Adolescent ; Agammaglobulinemia/diagnosis ; Agammaglobulinemia/immunology ; Anti-Inflammatory Agents, Non-Steroidal/adverse effects ; Arthritis, Juvenile/diagnosis ; Autoimmune Diseases/immunology ; Celecoxib/adverse effects ; Colitis, Ulcerative/genetics ; Colitis, Ulcerative/immunology ; Common Variable Immunodeficiency/genetics ; Common Variable Immunodeficiency/immunology ; Female ; Heterozygote ; Humans ; Inflammatory Bowel Diseases/chemically induced ; Inflammatory Bowel Diseases/immunology ; Whole Exome Sequencing
Czasopismo naukowe
Tytuł :
Association between inflammatory bowel disease and risk of abnormalities of uterine cervix.
Autorzy :
Cui Y; Department of Gynecology and Obstetrics, Dalian Municipal Central Hospital, Affiliated of Dalian Medical University, Dalian, China.
Jin X; Department of Gynecology and Obstetrics, Dalian Municipal Central Hospital, Affiliated of Dalian Medical University, Dalian, China.
Zhang H; Department of Gynecology and Obstetrics, Dalian Municipal Central Hospital, Affiliated of Dalian Medical University, Dalian, China.
Liu L; Department of Gynecology and Obstetrics, Dalian Municipal Central Hospital, Affiliated of Dalian Medical University, Dalian, China.
Pokaż więcej
Źródło :
The journal of obstetrics and gynaecology research [J Obstet Gynaecol Res] 2021 Nov; Vol. 47 (11), pp. 4030-4036. Date of Electronic Publication: 2021 Sep 15.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Inflammatory Bowel Diseases*/complications
Inflammatory Bowel Diseases*/epidemiology
Uterine Cervical Neoplasms*/epidemiology
Cohort Studies ; Female ; Humans ; Odds Ratio ; Risk
Czasopismo naukowe
Tytuł :
A review of ophthalmic manifestations of inflammatory bowel disease and associated treatments.
Autorzy :
Janardhana P; Department of Ophthalmology and Visual Sciences, University of Massachusetts Medical School, Worcester, MA, USA.
Al-Kadhi S
Pokaż więcej
Źródło :
Current opinion in ophthalmology [Curr Opin Ophthalmol] 2021 Nov 01; Vol. 32 (6), pp. 549-554.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Crohn Disease*
Inflammatory Bowel Diseases*/complications
Inflammatory Bowel Diseases*/drug therapy
Uveitis*/diagnosis
Uveitis*/drug therapy
Uveitis*/etiology
Humans ; Immunosuppressive Agents
Czasopismo naukowe
Tytuł :
Medications and the Risk of Colorectal Cancer in Patients with Inflammatory Bowel Diseases: Use of the Landmark Method.
Autorzy :
Choi YY; Artificial Intelligence Big Data Medical Center, Wonju College of Medicine, Yonsei University, Wonju, Korea.
Lee JK; Department of Biostatistics, Wonju College of Medicine, Yonsei University, Wonju, Korea.
Kim HS; Department of Internal Medicine, Wonju College of Medicine, Yonsei University, Wonju, Korea.
Kim DW; Department of Information and Statistics, Gyeongsang National University, Jinju, Korea.
Kim HM; Department of Internal Medicine, Wonju College of Medicine, Yonsei University, Wonju, Korea.
Kang DR; Department of Biostatistics, Wonju College of Medicine, Yonsei University, Wonju, Korea.; Department of Precision Medicine, Wonju College of Medicine, Yonsei University, Wonju, Korea. .
Pokaż więcej
Źródło :
Yonsei medical journal [Yonsei Med J] 2021 Nov; Vol. 62 (11), pp. 997-1004.
Typ publikacji :
Journal Article
MeSH Terms :
Colitis, Ulcerative*
Colorectal Neoplasms*/epidemiology
Crohn Disease*
Inflammatory Bowel Diseases*/complications
Inflammatory Bowel Diseases*/drug therapy
Cohort Studies ; Humans
Czasopismo naukowe
Tytuł :
The important role of fungi in inflammatory bowel diseases.
Autorzy :
Wang S; Laboratory of Translational Gastroenterology, Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Zhang YR; Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.; National Clinical Research Center for Obstetrics and Gynecology (Peking University Third Hospital), Beijing, China.; Key Laboratory of Assisted Reproduction, Ministry of Education (Peking University), Beijing, China.; Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing, China.
Yu YB; Department of Gastroenterology, Laboratory of Translational Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Pokaż więcej
Źródło :
Scandinavian journal of gastroenterology [Scand J Gastroenterol] 2021 Nov; Vol. 56 (11), pp. 1312-1322. Date of Electronic Publication: 2021 Aug 15.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Gastrointestinal Microbiome*
Inflammatory Bowel Diseases*
Dysbiosis ; Fungi ; Humans
Czasopismo naukowe
Tytuł :
Addressing unmet needs from a new frontier of IBD: the South Asian IBD Alliance.
Autorzy :
Aswani-Omprakash T; Master of Public Health Programme, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Sharma V; Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Bishu S; Crohn's and Colitis Center, University of Michigan, Ann Arbor, MI, USA.
Balasubramaniam M; Executive Council, South Asian IBD Alliance, Chennai, India.
Bhatia S; Institute of Digestive and Hepatobiliary Sciences, Medanta, The Medicity, Gurugram, India.
Nandi N; Inflammatory Bowel Diseases Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Shah ND; Crohn's and Colitis Disease Centre, University of San Francisco, San Francisco, CA, USA.
Deepak P; Division of Gastroenterology and Inflammatory Bowel Diseases Centre, Washington, WA, USA; Washington University in Saint Louis School of Medicine, St Louis, MO, USA.
Sebastian S; IBD Unit, Hull University Teaching Hospitals NHS Trust, Hull HU3 2JZ, UK; Hull York Medical School, Hull, UK. Electronic address: .
Pokaż więcej
Źródło :
The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2021 Nov; Vol. 6 (11), pp. 884-885.
Typ publikacji :
Journal Article
MeSH Terms :
Asian Continental Ancestry Group*
Patient Advocacy*
Healthcare Disparities/*ethnology
Inflammatory Bowel Diseases/*ethnology
Asia/epidemiology ; Culturally Competent Care ; Developed Countries ; Developing Countries ; Emigrants and Immigrants ; Europe/epidemiology ; Gene-Environment Interaction ; Health Education ; Health Services Accessibility ; Health Status Disparities ; Humans ; Inflammatory Bowel Diseases/diagnosis ; Inflammatory Bowel Diseases/etiology ; Inflammatory Bowel Diseases/therapy ; Needs Assessment ; North America/epidemiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies